03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards

Standardized plug-and-produce modules reduce infrastructure complexity. See how MTP-based automation allows life science plants to adapt quickly while accelerating overall time-to-market.

Discover how the updated ICH E6(R3) guideline supports the speed and complexity of CGT manufacturing, enabling flexible, risk‑based decisions and quality systems built to scale therapies safely.

Is 0.45 m/s at the working position a hard requirement or a convention? Assess a risk-based approach to Annex 1 compliance that balances contamination control with operational efficiency.

How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

Emerging psychiatric therapies are bring hope, but progress is fragile. Sustain innovation with biomarker-driven, mechanism-first approaches to help overcome biological, regulatory, and commercial barriers.

DIN values offer a data‑backed way to identify which DNA samples are ready for successful sequencing. With strong correlations to sequencing performance, DIN thresholds help streamline workflows.

Regulatory frameworks for biopharmaceutical cold chain management are more interconnected than most manufacturers expect — but mind the gaps that pose compliance risks.

In this collection, review how proven, automated solutions can help facilities stay compliant, operational, and protected during both emergency recovery phases and standard planned maintenance cycles.

Effective cleanroom management requires moving beyond checkbox compliance. Learn how to empower your workforce by connecting individual roles to broader contamination control goals and behaviors.